Natasha K. Brockwell
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma.
Journal: Translational lung cancer research
Published: July 18, 2020
Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancer.
Journal: Clinical & translational immunology
Published: June 14, 2020
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression.
Journal: Cancers
Published: November 14, 2019
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
Journal: NPJ precision oncology
Published: December 07, 2018
Interferon-ε is a tumour suppressor and restricts ovarian cancer.
Journal: Nature
Published: August 09, 2018
Tumor inherent interferons: Impact on immune reactivity and immunotherapy.
Journal: Cytokine
Published: February 11, 2018
Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Journal: The Journal of pathology
Published: July 04, 2017
Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.
Journal: Cancer immunology research
Published: March 27, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026